SKINVIVA REGENERATIVE RADIOTHERAPY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SKINVIVA REGENERATIVE RADIOTHERAPY Trademark

Serial Number: 79317444 • Registration: 7244858

SKINVIVA REGENERATIVE RADIOTHERAPY is a trademark filed by Genesis Specialist Care Holding UK Limited on March 10, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Genesis Specialist Care Holding UK Limited (15 trademarks)

Wilson House,

Entity Type: 16

Trademark Details

Filing Date

March 10, 2021

Registration Date

December 19, 2023

Published for Opposition

October 3, 2023

Goods & Services

Medical apparatus for use in administering radiation therapy; medical radiation apparatus in the nature of bolus for use in radiation therapy

Radiation oncology services; radiation oncology therapy services

Software as a service (SaaS) services featuring software for use in relation to pre-cancer treatment services, cancer treatment services, and radiation therapy services, namely, non-downloadable software for assessing the severity of skin cancerization and damage; software as a service (SAAS) services featuring software for the diagnosis, monitoring and treatment of medical and health conditions; software as a service (SAAS) services featuring software for the diagnosis, monitoring and treatment of skin conditions; software as a service (Saas) services software for the management of the medical patient experience; software as a service (SaaS) services featuring software for providing medical and health content; software as a service (SaaS) services featuring software for providing medical and health content relating to skin; software as a service (SaaS) services featuring software for harmonised care management of medical patients; software as a service (SaaS) services featuring software for medical patient administration

Downloadable computer software for use in relation to pre-cancer treatment services, cancer treatment services, and radiation therapy services, namely, software for assessing the severity of skin cancerization and damage; downloadable software applications for use in relation to pre-cancer treatment services, cancer treatment services, and radiation therapy services, namely, software for assessing the severity of skin cancerization and damage; electronic publications, namely, downloadable magazines, books, newsletters, and articles in the field of medicine; electronic publications, namely, downloadable magazines, books, newsletters, and articles featuring medical matters; digital downloadable electronic publications in the nature of questionnaires for medical assessments; downloadable computer software and software applications for the diagnosis, monitoring and treatment of medical and health conditions; downloadable computer software and software applications for the diagnosis, monitoring and treatment of skin conditions; downloadable computer software and software applications for the management of the medical patient experience; downloadable computer software and software applications for providing medical and health information; downloadable computer software and software applications for providing medical and health information relating to skin; downloadable computer software and software applications for harmonized care management of medical patients; downloadable computer software and software applications for medical patient administration

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 22, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 27, 2024 FICS
FINAL DISPOSITION PROCESSED
Mar 27, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 19, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 19, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 19, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Oct 3, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 13, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 25, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 16, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 21, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 21, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 21, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2023 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 31, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 11, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 11, 2023 OPNR
REFUSAL PROCESSED BY IB
Nov 7, 2022 RFNP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 12, 2022 CNRT
NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2022 NREP
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jul 25, 2022 LIME
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 21, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 21, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jun 21, 2022 CNSL
ASSIGNED TO EXAMINER
May 9, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 4, 2022 TROA
LIMITATION OF GOODS RECEIVED FROM IB
Apr 23, 2022 LIMG
REFUSAL PROCESSED BY IB
Nov 23, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 4, 2021 RFCS
REFUSAL PROCESSED BY MPU
Nov 4, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 7, 2021 RFCR
NON-FINAL ACTION WRITTEN
Oct 6, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 13, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 9, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 5, 2021 REPR